SHANNON SGRO: Open Payments
NPI 1396790358 · ROSEVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,620 in 81 payments from 18 companies in 2025. Trend: 2023 $1,702 · 2024 $2,238 · 2025 $1,620
Food & beverage: $1,620
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $240 |
| E.R. Squibb & Sons, L.L.C. | 11 | $188 |
| ABBVIE INC. | 11 | $178 |
| Galderma Laboratories, L.P. | 9 | $168 |
| Incyte Corporation | 6 | $146 |
| Lilly USA, LLC | 8 | $127 |
| Janssen Biotech, Inc. | 4 | $94 |
| LEO Pharma Inc. | 4 | $76 |
| Arcutis Biotherapeutics, Inc. | 4 | $70 |
| REVANCE THERAPEUTICS, INC. | 2 | $64 |
Products named: DUPIXENT, Sotyktu, OPZELURA, NEMLUVIO, TALTZ, RINVOQ, TREMFYA, SKYRIZI.
Industry payments across CA — which companies pay providers there.
